Cleerly offers a transformative digital care pathway for evaluation and management of Coronary Artery Disease (CAD). Leveraging latest-generation artificial intelligence (AI) frameworks, Cleerly’s solutions perform comprehensive and quantitative assessment of CAD, with clinical solutions delivered to imaging physicians, clinicians and patients.
A New Standard of Care
Shifting care paradigm from symptom-driven to risk-based
Transforming Images Into Intelligence
End-to-end AI-based approach to translate imaging science into actionable clinical insights
Innovative Patient-Specific Education
Improved technologies to allow a patient to visualize their own disease in order to optimize shared decision making and adherence to therapy
Phenotype-Driven Personalized Medicine
Only method to tailor therapy to an individual’s actual disease characteristics
Direct Non-invasive Disease Tracking
Only method to directly quantify disease progression or stabilization over time, and guide changes in medical therapy
Improve Clinically Appropriate Care
& Reduce Unnecessary Patient Risk
With Cleerly as a partner in your cardiac care assessment, your organization can make better informed diagnostic testing and treatment authorization decisions. With precise, patient specific data from Cleerly at hand, care decisions become personalized and more appropriate. From better coordinated care, comes better patient outcomes.
